Tag: Prescription Drugs

New Democrat Coalition Unveils Comprehensive U.S. Health Care Action Plan

The New Democrat Coalition released a Health Care Action Plan targeting healthcare affordability, access expansions, and protections for Medicaid and Medicare, proposing over 45 actionable policy reforms. The plan addresses cost reduction, rural healthcare support, behavioral health, women's health services, and counters health misinformation.

Medicare Advantage Plan Terminations in Rochester-Finger Lakes Region for 2026

Medicare Advantage plans in Rochester-Finger Lakes are terminating in 2026, requiring beneficiaries to select new plans by Dec 7 or revert to Original Medicare with higher costs. Understand the implications for prescription costs and coverage changes.

Medicare Part D Coverage Shrinks in 2026 Amid Plan Reductions and Cost Shifts

Medicare Part D faces significant plan reductions and rising costs in 2026. Beneficiaries must review their drug plans before the December 7 deadline to avoid premium hikes and coverage losses.

Medicare Drug Price Negotiations Expand to 15 More Medications in 2027

CMS expands Medicare drug price negotiations to 15 more medications starting in 2027, including popular diabetes and weight loss treatments, aiming to reduce prescription costs and save Medicare billions.

Medicare Part B Premiums Rise in 2026; Part D Drug Costs Slightly Decline

Medicare Part B premiums are set to rise significantly in 2026 amid medical inflation, while Part D prescription drug costs slightly decline nationally. Enrollment opens October 15 for plan changes including Medicare Advantage and Medigap options.

Senator Welch Urges Bipartisan Action to Protect ACA Tax Credits and Avoid Shutdown

Senator Peter Welch calls for bipartisan cooperation to extend ACA tax credits and prevent a government shutdown that threatens affordable healthcare for millions.

FDA Approves Leucovorin for Autism Amid Investment and Regulatory Clarifications

FDA approves prescription leucovorin for autism treatment; HHS addresses investment and regulatory concerns involving CMS administrator Dr. Mehmet Oz amid public discourse.

Healthcare Inflation Drives Highest Employer Coverage Cost Increase Since 2010

Rising healthcare inflation is leading to the largest health coverage cost increase for U.S. employers since 2010, driven by higher medical care prices and prescription drug expenses, especially GLP-1 drugs.

Medicare Coverage Limits for Saxenda Highlight Challenges in Weight Loss Drug Access

Explore Medicare coverage limitations for Saxenda, a GLP-1 agonist approved for weight loss, and the implications for obesity drug access and insurance plan strategies.

CMS Price-Substitution Policy Saves $76M on Medicare Drugs Since 2013

CMS's price-substitution policy has saved $76 million for Medicare by correcting drug pricing identified by the Office of Inspector General, improving cost efficiency while maintaining access.